Management of multifocal primary cutaneous CD30+ anaplastic large cell lymphoma

This publication has 22 references indexed in Scilit:

• Statistical Evaluation of Diagnostic and Prognostic Features of CD30+ Cutaneous Lymphoproliferative Disorders
  The American Journal of Surgical Pathology, 1998
• Primary cutaneous large-cell lymphoma: analysis of 49 patients included in the LNH87 prospective trial of polychemotherapy for high-grade lymphomas
  Leukemia, 1998
• Absence of anaplastic lymphoma kinase (ALK) and Epstein–Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis
  British Journal of Dermatology, 1997
• CD30 (Ki‐l)‐positive primary cutaneous T‐cell lymphoma: Report of spontaneous resolution
  Australasian Journal of Dermatology, 1997
• Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders
  Journal of the American Academy of Dermatology, 1996
• Anti‐CD30 (BER‐H2) immunotoxins containing the type‐1 ribosome‐inactivating proteins momordin and PAP‐S (pokeweed antiviral protein from seeds) display powerful antitumour activity against CD30⁺ tumour cells in vitro and in SCID mice
  British Journal of Haematology, 1996
• Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T‐cell or null cell phenotype
  Histopathology, 1993
• Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders: A proposal for classification and guidelines for management and treatment
  Journal of the American Academy of Dermatology, 1993
• Oral etoposide in the treatment of cutaneous large-cell lymphomas. A preliminary report of four cases
  British Journal of Dermatology, 1992
• Twelve cases of Ki-1 positive anaplastic large cell lymphoma of skin.
  Journal of Clinical Pathology, 1991